BioSIM 抗人 FcRn 抗体 (罗扎诺利珠单抗),生物类似药 5mg
文献支持

BioSIM 抗人 FcRn 抗体 (罗扎诺利珠单抗),生物

类似药 5mg
收藏
  • 询价
  • InvivoCrown
  • 英国
  • SIM0054-5mg
  • 2025年11月10日
  • ELISA, FACS, Functional assay, Research in vivo
  • Humanized
  • Human
  • 详细信息
  • 文献和实验
  • 技术资料
  • 免疫原

    该BioSIM 抗人 FcRn 抗体 (罗扎诺利珠单抗),生物类似药,科研用途 [ CAS: 1584645-37-3]的免疫原请参考该产品的说明书

  • 保存条件

    为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。

  • 克隆性

    单克隆

  • 适应物种

    Human

  • 保质期

    为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。

  • 级别

    科研级别

  • 库存

    999

  • 供应商

    亚科因(Abbkine)

  • 宿主

    Humanized

  • 应用范围

    ELISA, FACS, Functional assay, Research in vivo

  • 抗体英文名

    FcRn

  • 抗体名

    FcRn

  • 规格

    5mg

BioSIM 抗人 FcRn 抗体 (罗扎诺利珠单抗) - 生物类似药(科研用途)

英文名称:BioSIM anti-Human FcRn Antibody (Rozanolixizumab Biosimilar), Research Grade

产品基本信息

  • 货号:SIM0054-5mg
  • 规格:5mg
  • 供应商:InvivoCrown
  • 产品类型:重组生物类似二抗
  • CAS号:1584645-37-3
  • 来源宿主:人源化(Humanized)
  • 反应性:仅识别人源(Human)抗原

产品背景与生产工艺

本产品为罗扎诺利珠单抗(Rozanolixizumab)的生物类似抗体,靶向人源FcRn(新生儿Fc受体),适用于科研领域相关机制研究。其生产过程遵循严格的杂质控制标准:

  • 采用无动物成分的专用生产设施,全程避免动物源性蛋白、病毒等杂质引入;
  • 使用体外无蛋白细胞培养技术,减少非目标蛋白对产品纯度的干扰;
  • 多步骤纯化组合工艺,包含Protein A/G亲和色谱核心步骤,确保抗体纯度与结合特异性。

关联研究领域:血小板减少症重症肌无力(与FcRn介导的IgG代谢异常相关疾病)。

适用科研应用

本抗体支持多场景实验应用,具体如下:

  • ELISA:用于定量检测抗原-抗体结合反应,可应用于FcRn蛋白表达水平分析;
  • FACS(荧光激活细胞分选):分析细胞表面FcRn的表达分布与相对含量;
  • Functional Assay(功能实验):评估抗体对FcRn介导的IgG转运/回收功能的调控;
  • 体内研究(Research in vivo):用于动物模型中探索FcRn靶点相关疾病的病理机制。

注:具体实验 protocol 请参考产品附带说明书。

储存与稳定性建议

为保障产品活性与稳定性,需严格遵循以下储存条件:

  • 短期使用(1-2周):4°C避光保存,避免反复冻融;
  • 中期储存(最长12个月):-20°C避光保存,建议分装为小体积(如100μg/管)以减少冻融次数;
  • 长期储存(12个月以上):-80°C避光保存,分装后可长期保持活性。

重要提示:反复冻融会导致抗体构象破坏,显著降低结合活性,需严格避免。

注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

亚科因(Abbkine)

BioSIM anti-Human FcRn Antibody (Rozanolixizumab) - Biosimilar (Research Use)

English Name:BioSIM anti-Human FcRn Antibody (Rozanolixizumab Biosimilar), Research Grade

Basic Product Information

  • Catalog No.:SIM0054-5mg
  • Size:5mg
  • Supplier:InvivoCrown
  • Product Type:Recombinant Biosimilar Secondary Antibody
  • CAS No.:1584645-37-3
  • Source Host:Humanized
  • Reactivity:Reacts specifically with Human antigen

Product Background and Manufacturing Process

This product is a biosimilar antibody of Rozanolixizumab, targeting human FcRn (Neonatal Fc Receptor), suitable for mechanism research in scientific fields. Its manufacturing process follows strict impurity control standards:

  • Utilizesanimal component-free dedicated production facilities to prevent introduction of animal-derived proteins, viruses, and other impurities throughout the process;
  • Employsprotein-free in vitro cell culture technology to reduce interference from non-target proteins on product purity;
  • Undergoesmulti-step purification combination process, including Protein A/G affinity chromatography as the core step, ensuring antibody purity and binding specificity.

Related research fields: Thrombocytopenia, Myasthenia Gravis (diseases associated with FcRn-mediated IgG metabolic abnormalities).

Applicable Research Applications

This antibody supports various experimental applications, as follows:

  • ELISA: For quantitative detection of antigen-antibody binding reactions, applicable to FcRn protein expression level analysis;
  • FACS (Fluorescence-Activated Cell Sorting): Analysis of expression distribution and relative content of FcRn on cell surface;
  • Functional Assay: Evaluation of antibody regulation on FcRn-mediated IgG transport/recycling function;
  • Research in vivo: Used for exploring pathological mechanisms of FcRn target-related diseases in animal models.

Note: For specific experimental protocols, please refer to the product instruction manual.

Storage and Stability Recommendations

To ensure product activity and stability, the following storage conditions must be strictly followed:

  • Short-term use (1-2 weeks): Store at 4°C protected from light, avoid repeated freeze-thaw cycles;
  • Medium-term storage (up to 12 months): Store at -20°C protected from light, recommended to aliquot into small volumes (e.g., 100μg/tube) to reduce freeze-thaw cycles;
  • Long-term storage (more than 12 months): Store at -80°C protected from light, aliquoted product can maintain activity for extended periods.

Important Note: Repeated freeze-thaw cycles can cause antibody conformational damage and significantly reduce binding activity, which should be strictly avoided.

Note: The above information may be subject to change due to product optimization and upgrades. For specific information, please contact InvivoCrown.

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

图标文献和实验
该产品被引用文献
BioSIM anti-Human FcRn Antibody (Rozanolixizumab Biosimilar), Research Grade
图标技术资料

暂无技术资料 索取技术资料

同类产品报价

产品名称
产品价格
公司名称
报价日期
询价
亚科因(武汉)生物技术有限公司
2025年11月10日询价
询价
武汉佰瑞得生物技术有限公司
2025年07月11日询价
¥600
天府新区华阳正龙生化制品研究室
2025年12月17日询价
询价
维百奥(北京)生物科技有限公司
2025年07月09日询价
文献支持
BioSIM 抗人 FcRn 抗体 (罗扎诺利珠单抗),生物类似药 5mg
询价